All About Toxicology

Home » Events/Calendar » Webinars » All About Toxicology

All About Toxicology

User instructions: Hover over the speaker's image to reveal his or her biography. If using a mobile device, tap the speaker's image to reveal his or her biography.

Presentation 1

Presentation Summary:

During this session, we will review key considerations in determining donor eligibility in death involving prescription and illicit drugs. In addition to the concern for RCDADs, we will evaluate implications on tissue quality and viability as a result of chronic and acute drug involvement and toxicity.

Dr. Ray

Dr. Ray

Dr. Gregory Ray is the Medical Director at CryoLife in Kennesaw, GA. Dr. Ray is past Chair of the AATB Physicians’ Council, has served on the AATB Board of Governors, and is currently on the AATB Standards Committee. Dr. Ray received his B.S. degree in Biology from Oglethorpe University in Atlanta, GA and his MD degree from Medical College of Georgia in Augusta, GA. He completed a fellowship in Molecular Medicine at the Institute for Molecular Medicine and Genetics at MCG.

He completed postgraduate training in Anatomic Pathology and Laboratory Medicine and was Chief Resident at Emory University in 2000. Dr. Ray is certified by the American Board of Pathology in both Anatomic and Clinical Pathology, with a special interest in cardiovascular pathology. He is a fellow of the College of American Pathologists and a member of the Society of Cardiovascular Pathology. Prior to joining CryoLife in 2003, Dr. Ray served as Laboratory Medical Director and Staff Pathologist in four Atlanta area community hospitals.

Drug Related Deaths & Eligibility

 

Speaker: Dr. Gregory Ray
Date: July 10, 2019
Time: 2:00 p.m. - 3:00 p.m. EST

 

Presentation 2

Presentation Summary:

During this session, we will discuss the processes and challenges in forensic toxicology. In addition, we will explore unique cases and rare toxicology-related deaths.

Modern Toxicology & Challenges

 

Speaker: Robert Middleberg, PhD
Date: July 24, 2019
Time: 2:00 p.m. - 3:00 p.m. EST

 

Presentation 3

Presentation Summary:

During this session, we will review the current trends in overdose deaths with a focus on opioid-related deaths. We will evaluate the challenges involved with designer drugs and the effective screening of these unknown substances.

Dr. Weedn

Dr. Weedn

Victor Weedn, MD, JD, is a forensic pathologist, attorney, Professor in the George Washington University Department of Forensic Sciences and past President of the American Academy of Forensic Sciences. He has worked as a medical examiner, crime laboratory director and academic. He founded the military’s DNA identification program, pioneered capillary electrophoretic DNA fragment separation, mitochondrial sequencing and microchip technology, and oversaw the Armed Forces Identification Laboratory (AFDIL), which identified Czar Nicholas II of Russia, the Branch Davidian victims, and later Michael Blassie, the Vietnam unknown of the Tomb of the Unknown. He has worked on mass graves in Iraq to develop evidence against Saddam Hussein. He holds a patent on latent fingerprint technology. He led the establishment of the current NAME accreditation program and participated in the establishment of clinical molecular pathology standards for the College of American Pathologists. He was recently detailed to DOJ as the Senior Forensic Advisor to Deputy Attorney General Sally Yates. He testified before Congress in March on Forensic Science Reform. He is currently involved in the opioid crisis response.

The Current State of Drug Related Deaths

 

Speaker: Victor Weedn, MD, JD
Date: July 31, 2019
Time: 2:00 p.m. - 3:00 p.m. EST